The Enterprise Value as of November 2025 (TTM) for ISR Immune System Regulation Holding AB (publ) (ISR.ST) is 42.87M

According to ISR Immune System Regulation Holding AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 42.87M. This represents a change of -229.44% compared to the average of -33117250.00 of the last 4 quarters.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Historical Enterprise Value (quarterly & annually)

How has ISR.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of ISR Immune System Regulation Holding AB (publ) over the last ten years is 236.65M. The current 42.87M Enterprise Value has changed 1.71% with respect to the historical average. Over the past ten years (40 quarters), ISR.ST's Enterprise Value was at its highest in in the December 2017 quarter at 269.78M. The Enterprise Value was at its lowest in in the December 2021 quarter at -53747000.00.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ISR Immune System Regulation Holding AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Average Enterprise Value

How has ISR.ST Enterprise Value performed in the past?

The current Enterprise Value of ISR Immune System Regulation Holding AB (publ) (ISR.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ISR Immune System Regulation Holding AB (publ) (ISR.ST) Enterprise Value vs. Peers

How is ISR.ST’s Enterprise Value compared to its peers?

ISR Immune System Regulation Holding AB (publ)’s Enterprise Value is greater than CombiGene AB (publ) (-24839036.00), greater than Idogen AB (publ) (7.48M), greater than Kancera AB (publ) (8.45M), greater than Pharmiva AB (publ) (-1197289.00), greater than Cyxone AB (publ) (-9918956.00), greater than Ziccum AB (publ) (7.88M), greater than Scandion Oncology A/S (-11962272.60), greater than Amniotics AB (publ) (9.13M), greater than Asarina Pharma AB (publ) (-1527041.00), less than Toleranzia AB (126.88M),

Build a custom stock screener for ISR Immune System Regulation Holding AB (publ) (ISR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ISR Immune System Regulation Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ISR Immune System Regulation Holding AB (publ) (ISR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ISR Immune System Regulation Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.